Modern treatments
How TMS (Transcranial Magnetic Stimulation) therapy is evolving in 2026
Transcranial Magnetic Stimulation has undergone significant evolution since its FDA clearance for depression in 2008. In 2026, TMS is no longer a last-resort option — it's becoming a mainstream treatment with expanding applications and faster protocols.
What's new in TMS
The Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT) protocol, developed at Stanford University, delivers a full course of TMS in just 5 days instead of the traditional 6-9 weeks. Clinical trials showed remission rates of approximately 79% for treatment-resistant depression — dramatically higher than traditional TMS. This protocol uses MRI-guided targeting to identify the optimal stimulation site for each individual patient, representing a shift toward personalized neuromodulation.
Expanding applications
Beyond depression, TMS is now FDA-cleared for OCD (using deep TMS with H-coil technology) and is being studied for PTSD, anxiety disorders, substance use disorders, and chronic pain. Research into TMS for smoking cessation and opioid cravings is showing promising early results.
What a TMS session looks like
You sit in a chair (similar to a dentist's chair). A magnetic coil is placed against your scalp. You feel a tapping sensation during stimulation. Each session lasts 3-20 minutes depending on the protocol. You're awake the entire time and can drive yourself home afterward. There's no anesthesia, no sedation, and no recovery period. Most patients report mild scalp discomfort during the first few sessions that diminishes over time.
Finding a TMS provider
TMS is offered by psychiatrists, neurologists, and some specialized clinics. When evaluating providers, ask: What protocol do you use? How many TMS patients have you treated? Do you use neuronavigation (MRI-guided targeting)? Does my insurance cover TMS? (Many plans now cover FDA-cleared TMS for depression after medication trials have failed.)